hiv medication

Product Category: Prescription Antiviral Medicine Active Ingredients: Tenofovir Alafenamide 25 mg + Emtricitabine 200 mg + Rilpivirine 50 mg Dosage Form: Tablet Route: Oral Availability: Subject to applicable pharmaceutical regulations Product Overview TAFFIC 50/200/25 mg is a combination antiretroviral medicine containing rilpivirine, emtricitabine, and tenofovir alafenamide. These active ingredients belong to different classes of antiretroviral medicines and are used in the management of HIV-1 infection as part of an appropriate treatment regimen. Key Product Information Brand: TAFFIC Strength: Rilpivirine 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg Dosage Form: Tablet Therapeutic Category: Antiretroviral Administration: Oral Prescription Status: Prescription medicine Storage: Store according to the manufacturer's labeled instructions. Product Features Fixed-dose combination formulation Contains three antiretroviral active ingredients Intended for use under qualified medical supervision Convenient oral tablet formulation Export & Trading Information International pharmaceutical supply is subject to the regulations of both the exporting and importing countries. Product registration, import permits, prescription requirements, labeling requirements, and other regulatory documentation may apply depending on the destination market. Buyers and importers should verify local regulatory requirements and obtain the necessary approvals before placing an order. Trading FAQs Q1. What is TAFFIC 50/200/25 mg used for? It is an antiretroviral combination used in the management of HIV-1 infection under medical supervision. Q2. What are the active ingredients in TAFFIC? The formulation contains rilpivirine, emtricitabine, and tenofovir alafenamide. Q3. Is TAFFIC a prescription medicine? Yes. It should be used only under appropriate medical supervision and according to applicable prescribing requirements. Q4. Can TAFFIC be exported internationally? International export and import depend on the pharmaceutical regulations of the countries involved, including product registration and import requirements. Q5. What documents may be required for pharmaceutical trading? Depending on the destination, documentation may include commercial invoices, packing lists, certificates of analysis, GMP documentation, import permits, and other regulatory documents. Contact Us 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 7218129896 Medicine India Export International Pharmaceutical Trading & Export Enquiries